• AIBP-LRP2–HDL Axis Limits CXCR4+ Capillary Expansion in Isch

  2026-06-21

  The referenced study uncovers a two-phase mechanism by which AIBP-LRP2–mediated high-density lipoprotein (HDL) uptake restricts the expansion of CXCR4+ stem-like capillary endothelial cells, thus limiting collateral circulation in ischemic tissue. These insights clarify how lipid metabolism and microenvironmental signals modulate vascular remodeling, opening new avenues for therapeutic revascularization strategies.

• Cholecystokinin Octapeptide Ammonium: Mechanistic Insights &

  2026-06-20

  Explore the molecular mechanisms and nuanced experimental considerations of Cholecystokinin octapeptide ammonium (CCK-8 ammonium) in neurobehavioral and immunological research. This article delivers in-depth analysis and practical guidance to enhance assay accuracy, building on recent literature and unique mechanistic findings.

• Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO): Techn

  2026-06-19

  The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) addresses the challenge of preserving protein integrity during extraction, especially for workflows incompatible with EDTA and sensitive to divalent cations. It is best suited for applications such as Western blotting, co-immunoprecipitation, and kinase assays. This product should not be used in workflows where EDTA is required or when DMSO intolerance is expected.

• Leucovorin Calcium (SKU A2489): Reliable MTX Rescue & Assay

  2026-06-19

  Laboratories modeling drug resistance or cell viability often struggle with inconsistent protection from methotrexate-induced growth suppression and assay reproducibility. This article explores how Leucovorin Calcium (SKU A2489) delivers validated, reproducible solutions for cell proliferation and cytotoxicity assays. Researchers will discover practical protocol guidance, vendor comparisons, and insights for robust folate metabolism pathway modeling.

• Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO): Pract

  2026-06-18

  The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) addresses proteolytic degradation during protein extraction, especially in workflows sensitive to divalent cations. It is best applied in phosphorylation analysis, kinase assays, and any protein workflow where EDTA could interfere. It is not suitable where metal chelation is specifically required.

• DiR (DiIC 18 (7)): Enabling Deep-Red Membrane Imaging in Pre

  2026-06-18

  Explore how DiR (DiIC 18 (7)) revolutionizes membrane imaging for live cell, fixed tissue, and targeted nanomedicine research. This article delivers a deep technical analysis and connects breakthrough reference innovations to real-world assay workflow decisions.

• Mubritinib (TAK 165): Precision Complex I Inhibition in Canc

  2026-06-17

  Mubritinib (TAK 165) stands out as a mitochondrial complex I inhibitor delivering selective cytotoxicity in chemotherapy-resistant AML and KSHV-associated PEL models, while sparing healthy cells. This article details advanced workflows, troubleshooting, and the translational significance of Mubritinib for applied cancer and viral latency research.

• Stabilizing RNA Lipid Nanoparticles for Pulmonary Delivery

  2026-06-17

  This study presents a generalizable strategy to stabilize RNA-loaded lipid nanoparticles (LNPs) during nebulization by optimizing excipient and buffer composition. The results improve the reliability of inhalable RNA therapeutics delivery, with direct implications for advancing pulmonary gene therapy and functional mRNA studies.

• Ziprasidone HCl: Bridging Neuro-Oncology for Translational I

  2026-06-16

  This thought-leadership article explores the dual mechanistic profile of Ziprasidone Hydrochloride, illuminating its roles in dopaminergic and serotonergic pathway modulation as well as GOT1 inhibition for cancer metabolism disruption. Translational researchers are guided through mechanistic evidence, experimental validation—including nanocrystal permeability advances—and actionable protocol parameters. The narrative highlights how APExBIO’s Ziprasidone HCl enables cross-domain research, sets new standards for workflow optimization, and maps the future of neuro-oncology translation.

• A40926: Molecular Regulation and Advanced Use in Antibiotic

  2026-06-16

  Delve into the biosynthetic regulation and modern research applications of A40926, the dalbavancin precursor. This article uniquely explores molecular production control, practical assay design, and future directions in combating antibiotic resistance.

• Analytical Methods for Rotigotine: Ensuring Purity and Stabi

  2026-06-15

  This review systematically examines analytical approaches for quantifying rotigotine and its impurities in raw materials and pharmaceutical formulations. By comparing pharmacopeial and literature-based methods, the study highlights advances and ongoing challenges in quality control, with direct implications for research and development of dopaminergic therapeutics.

• Irinotecan (CPT-11): Mechanistic Frontiers in Colorectal Can

  2026-06-15

  This thought-leadership article explores the mechanistic rationale and translational strategy underpinning Irinotecan (CPT-11) use in colorectal cancer research. By integrating state-of-the-art experimental validation, competitive landscape analysis, and clinical translation, it provides actionable guidance for researchers aiming to maximize the impact of DNA damage and apoptosis modeling. The discussion is anchored in recent workflow advancements and contextualized against evolving needs in preclinical and translational oncology.

• DAF-2 Diacetate: High-Sensitivity Live-Cell Nitric Oxide Ima

  2026-06-14

  DAF-2 diacetate is a validated, cell-permeable fluorescent probe enabling nanomolar-scale detection of nitric oxide in live cells. Its robust mechanism ensures stable signal retention, supporting precise NO signaling pathway studies in both plant and animal models.

• METTL16-SENP3-LTF Axis Drives Ferroptosis Resistance in HCC

  2026-06-13

  Wang et al. elucidate how the METTL16-SENP3-LTF signaling axis confers resistance to ferroptosis and promotes tumorigenesis in hepatocellular carcinoma (HCC). This study reveals mechanistic links between m6A RNA modification, iron homeostasis, and HCC progression, offering a new therapeutic target for sensitizing tumors to ferroptosis.

• Stable Five-Element Nanoparticles for Lung-Specific mRNA Del

  2026-06-12

  This article examines the development of five-element nanoparticles (FNPs) incorporating poly(β-amino esters) and DOTAP, which provide highly stable, lung-targeted mRNA delivery after lyophilization. The study demonstrates how optimizing nanoparticle composition dramatically extends storage at 4°C, with significant implications for mRNA therapeutics and global distribution.

408 records 11/28 page Previous Next First page 上5页 1112131415 下5页 Last page